NRD
NRC icon

Nebula Research & Development’s NRC Health Common Stock NRC Stock Holding History

Nebula Research & Development’s Portfolio NRC Stock Details NRC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-10,364
Closed -$237K – 1043
2024
Q3 		$237K Buy
10,364
+660
+7% +$14.9K 0.03% 788
2024
Q2 		$223K Buy
+9,704
New +$299K 0.04% 701

Other funds holding NRC

Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
QI
QV Investors Calgary, Alberta, Canada $1.3B AUM 31.14% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Nebula Research & Development's NRC Position: Q4 2024 in Review

Nebula Research & Development sold out of NRC Health Common Stock (NRC) in Q4 2024, closing a stake of 10,364 shares — an estimated $237K sold.

Nebula Research & Development first reported a position in NRC in Q2 2024 and held it in 2 quarters. The position peaked at $237K in Q3 2024. 133 funds tracked by Wall St. Rank hold NRC as of Q4 2024.

  • Nebula Research & Development reported no remaining NRC Health Common Stock position as of Q4 2024 after selling out during the quarter.
  • Nebula Research & Development sold 10,364 NRC Health Common Stock shares in Q4 2024, an estimated $237K.
  • Nebula Research & Development first reported a position in NRC Health Common Stock in Q2 2024 and held it in 2 quarters.
  • Nebula Research & Development's NRC Health Common Stock position peaked at $237K in Q3 2024.
  • 133 funds tracked by Wall St. Rank held NRC Health Common Stock as of Q4 2024.

Based on Nebula Research & Development's 13F filing for Q4 2024, filed 14 Feb 2025.